To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis

Clinical trial NCT05135910 · UNKNOWN

Trial details

NCT number: NCT05135910
Sponsor: Hallux, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Onychomycosis of Toenail

Start date: 2022-01-13
Primary completion: 2024-09-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.